نتایج جستجو برای: bypassing

تعداد نتایج: 3464  

Journal: :Hematology. American Society of Hematology. Education Program 2014
Christine L Kempton Shannon L Meeks

Treatment of patients with hemophilia A and B has undergone significant advances during the past 2 decades. However, despite these advances, the development of antibodies that inhibit the function of infused clotting factor remains a major challenge and is considered the most significant complication of hemophilia treatment. This chapter reviews current tools available for the care of patients ...

Journal: :Vascular Health and Risk Management 2007
Geir E Tjønnfjord Pål Andre Holme

The development of high-titer inhibitors to FVIII and less often to other coagulation factors are the most serious complication of hemophilia therapy and makes treatment of bleeds very challenging. At present, bypassing agents, such as factor eight inhibitor bypass activity (FEIBA) and activated recombinant factor VII (rFVIIa) are the only coagulation factor concentrates available for the treat...

Journal: :Journal of Geophysical Research: Earth Surface 2016

Journal: :Proceedings of the National Academy of Sciences 2003

Journal: :Circulation: Arrhythmia and Electrophysiology 2019

Journal: :Journal of Statistical Mechanics: Theory and Experiment 2011

Journal: :International Journal of Information Technology and Computer Science 2013

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید